Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.

Nussrat SW, Ad'hiah AH

DOI: 10.1016/j.imlet.2023.01.006
Published: 2023 Feb
Container: Immunology letters
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.imlet.2023.01.006,
  title = {Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.},
  author = {Nussrat SW and Ad'hiah AH},
  year = {2023},
  journal = {Immunology letters},
  doi = {10.1016/j.imlet.2023.01.006},
  url = {https://doi.org/10.1016/j.imlet.2023.01.006}
}

RIS

TY  - JOUR
TI  - Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.
AU  - Nussrat SW
AU  - Ad'hiah AH
PY  - 2023
JO  - Immunology letters
DO  - 10.1016/j.imlet.2023.01.006
UR  - https://doi.org/10.1016/j.imlet.2023.01.006
ER  -

APA

SW, N., & AH, A. (2023). Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk.. Immunology letters. https://doi.org/10.1016/j.imlet.2023.01.006

Source records

pubmed · retrieved 2026-09-25T01:25:19.120Z